Haemophagocytic lymphohistiocytosis following COVID-19 mRNA vaccination
10.1136/bcr-2021-247022
March 16, 2022
Immunological products and vaccines
Clear cell renal cell carcinoma with stage IV cavoatrial tumour thrombus extension and rapid metastatic reoccurrence postsurgical treatment with review of current treatment strategies
10.1136/bcr-2021-248156
March 16, 2022
Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine
10.1136/bcr-2022-248927
March 15, 2022
Acute-onset dacryoadenitis following immunisation with mRNA COVID-19 vaccine
10.1136/bcr-2021-248441
March 7, 2022
Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
10.1136/bcr-2021-244638
March 4, 2022
Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy
10.1136/bcr-2021-246533
March 2, 2022
Acute respiratory distress syndrome precipitated by granulocyte colony-stimulating factor in undiagnosed pneumonia
10.1136/bcr-2021-242316
February 3, 2022
Rare case of interstitial nephritis in a young adult under IgG therapy
10.1136/bcr-2021-246651
February 2, 2022
Non-infective cystitis secondary to benralizumab immunotherapy
10.1136/bcr-2021-244733
January 17, 2022
Immunotherapy in stage IV non-small cell lung cancer in a patient with Grave’s disease: safety and biomarkers of response
10.1136/bcr-2021-245632
January 17, 2022